ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

IsoPlexis research offers hope for targeted CAR-T treatment – The Pharma Letter (registration)

Continue reading

2017-04-07 Michael Zand NEWS

The synthetic biology community is divided on intellectual property. – Slate Magazine

IsoPlexis research offers hope for targeted CAR–T treatment
The Pharma Letter (registration)
US-based biotech firm IsoPlexis has presented findings from research using the company’s precision engineering platform, called IsoCode. The data show the potential to predict whether cancer patients will respond to CAR–T cell therapy prior to …

Continue reading

2017-04-07 Michael Zand NEWS

Preprint peek-a-boo; vexing vacancy; CRISPR conundrum – Spectrum


Slate Magazine

The synthetic biology community is divided on intellectual property.
Slate Magazine
As with many new fields, synthetic biology—which incorporates disparate disciplines like engineering, computer science, biotechnology, and molecular bi …
Synthetic Biology Market to Exceed US$ 38 Billion Globally by 2020MilTech

all 2 news articles »

Continue reading

2017-04-07 Michael Zand NEWS

Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts – BioPharma-Reporter.com


Spectrum

Preprint peek-a-boo; vexing vacancy; CRISPR conundrum
Spectrum
More and more biologists are posting their papers on preprint servers, making their findings public before they’ve been through the drawn-out process of peer review. Not all journal publishers welcomed this new culture of openness at first, but most …

Continue reading

2017-04-07 Michael Zand NEWS

Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts – BioPharma-Reporter.com


BioPharma-Reporter.com

Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts
BioPharma-Reporter.com
Such cells come from bone marrow, adipose tissue and umbilical cord blood but are very rare, according to Ana Fernandes-Platzgummer, a research scientist for the Stem Cell Engineering Research Group at the Instituto Superior Técnico in Lisbon, Portugal.
Provia Laboratories, cGMP Autologous Stem Cell Company, Launches $2M Growth Capital Financing Round …PR Web (press release)

all 3 news articles »

Continue reading

2017-04-07 Michael Zand NEWS

New CAR-T and Stem Cell Facilities at CBMG – BSI bureau (press release)

BSI bureau (press release)New CAR-T and Stem Cell Facilities at CBMGBSI bureau (press release)Cellular Biomedicine Group Inc. (CBMG) is a clinical- stage biopharmaceutical firm involved in developing effective immunotherapies for cancer and stem cell t… Continue reading

2017-04-07 Michael Zand NEWS

New CAR-T and Stem Cell Facilities at CBMG – BSI bureau (press release)

BSI bureau (press release)New CAR-T and Stem Cell Facilities at CBMGBSI bureau (press release)Cellular Biomedicine Group Inc. (CBMG) is a clinical- stage biopharmaceutical firm involved in developing effective immunotherapies for cancer and stem cell t… Continue reading

2017-04-07 Michael Zand NEWS

Cancer and Immunotherapy Symposium Hosted by ACEA Biosciences Gathers Clinicians and Scientists From Around … – Yahoo Finance

Cancer and Immunotherapy Symposium Hosted by ACEA Biosciences Gathers Clinicians and Scientists From Around …Yahoo FinanceArmed with this type of information, Overstreet spoke about the prospect of assembling a collection of effector cells from diffe… Continue reading

2017-04-07 Michael Zand NEWS
  • 1
  • …
  • 1,871
  • 1,872
  • 1,873
  • 1,874
  • 1,875
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

BioPharma-Reporter.com

Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts
BioPharma-Reporter.com
Such cells come from bone marrow, adipose tissue and umbilical cord blood but are very rare, according to Ana Fernandes-Platzgummer, a research scientist for the Stem Cell Engineering Research Group at the Instituto Superior Técnico in Lisbon, Portugal.
Provia Laboratories, cGMP Autologous Stem Cell Company, Launches $2M Growth Capital Financing Round …PR Web (press release)

all 3 news articles »